These ten images can help ob/gyns recognize the additional information GBCA administration provides in MRIs.
Rola Saouaf, MD
Advertisement
Articles by Rola Saouaf, MD
Gadolinium-based intravenous contrast agents (GBCA) provide additional information based on signal intensity changes after GBCA administration.
Concerns have been raised about the safety of GBCA. Experts review the latest data to support counseling of patients who may have repeated exposure.
Advertisement
Latest Updated Articles
Gadolinium-based contrast in breast MRI: What ob/gyns need to knowPublished: September 19th 2019 | Updated:
8 examples of how GBCA improves MRIPublished: October 3rd 2019 | Updated:
The value of GBCA in MRI imagesPublished: November 4th 2019 | Updated:
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Contemporary OB/GYN week in review: birth complications, fasting, and more
2
Eve Zaritsky, MD, highlights improved oral contraceptive access from e-visits
3
Breakthrough endometriosis test detects biomarker in menstrual blood
4
Survey reveals misconceptions about pregnancy safety for older women
5
